Back to HomeBeta

ICD-10 Coding for Metastatic Breast Carcinoma(C50.912, C79.51)

Complete ICD-10-CM coding and documentation guide for Metastatic Breast Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic Breast CancerSecondary Breast Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Breast Carcinoma

C50.0-C50.9Primary Range

Malignant neoplasm of breast

Primary codes for breast cancer, specifying location and laterality.

Secondary malignant neoplasms of brain and bone

Codes for metastases to specific sites like brain and bone.

Secondary malignant neoplasm of liver

Code for liver metastasis from breast cancer.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C50.912Malignant neoplasm of unspecified site of left female breastUse when the primary site is confirmed as the left breast but specific quadrant is not documented.
  • Pathology report confirming invasive ductal carcinoma
  • Imaging showing primary breast tumor
C79.51Secondary malignant neoplasm of boneUse when metastasis to bone is confirmed.
  • Bone scan showing metastatic lesions
  • Biopsy confirming breast origin

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for metastatic breast carcinoma

Essential facts and insights about Metastatic Breast Carcinoma

The ICD-10 code for metastatic breast carcinoma varies by metastasis site, such as C79.51 for bone or C78.7 for liver.

Primary ICD-10-CM Codes for metastatic breast carcinoma

Malignant neoplasm of unspecified site of left female breast
Billable Code

Decision Criteria

documentation Criteria

  • Document laterality and specific site for accurate coding.

Applicable To

  • Breast cancer, NOS

Excludes

  • Benign neoplasm of breast

Clinical Validation Requirements

  • Pathology report confirming invasive ductal carcinoma
  • Imaging showing primary breast tumor

Code-Specific Risks

  • Risk of unspecified coding if quadrant is known but not documented.

Coding Notes

  • Ensure laterality is documented to avoid unspecified coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use to indicate chemotherapy treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of unspecified site of unspecified female breast

C50.919
Use when neither laterality nor specific site is documented.

Malignant neoplasm of bone and articular cartilage, unspecified

C41.9
Use for primary bone cancer, not metastasis.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Metastatic Breast Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C50.912.

Impact

Clinical: May affect treatment decisions., Regulatory: Increases audit risk., Financial: Potential for reduced reimbursement.

Mitigation Strategy

Always document laterality in clinical notes.

Impact

Reimbursement: May lead to reduced reimbursement due to unspecified coding., Compliance: Increases risk of audit findings., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Query provider for specific site and laterality.

Impact

Using unspecified codes when specific details are available.

Mitigation Strategy

Ensure documentation includes specific site and laterality.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Metastatic Breast Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Metastatic Breast Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Metastatic Breast Carcinoma. These templates include all required elements for proper coding and billing.

Metastatic breast cancer with bone metastasis

Specialty: Oncology

Required Elements

  • Primary site documentation
  • Metastasis site confirmation
  • Treatment plan

Example Documentation

Patient with ER+ invasive ductal carcinoma of left breast (C50.912) with confirmed bone metastasis (C79.51).

Examples: Poor vs. Good Documentation

Poor Documentation Example
Breast cancer with mets.
Good Documentation Example
Stage IV ER+/HER2- invasive ductal carcinoma (C50.212) with confirmed hepatic metastases (C78.7) per MRI and biopsy (3/28/25). Current regimen: paclitaxel + trastuzumab.
Explanation
The good example specifies cancer type, stage, metastasis site, and treatment, improving clarity and coding accuracy.

Need help with ICD-10 coding for Metastatic Breast Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more